Wagle, Anjali A http://orcid.org/0000-0002-6475-5774
Isakadze, Nino
Nasir, Khurram
Martin, Seth Shay
Article History
Accepted: 11 February 2021
First Online: 10 March 2021
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Khurram Nasir is on the Advisory Boards of Amgen, Novartis, and The Medicines Company, and his research is partly supported by the Jerold B. Katz Academy of Translational Research.Seth Shay Martin reports personal fees from Amgen, AstraZeneca, Esperion, REGENXBIO, and 89bio; grants from Apple, Google, iHealth, Nokia, Maryland Innovation Initiative, American Heart Association, Aetna Foundation, PJ Schafer Memorial Fund, David and June Trone Family Foundation, Akcea Therapeutics,and the National Institutes of Health; and is co-founder of Corrie Health, LLC. In addition, Dr. Martin has a pending patent on System of LDL-C Estimation.The other authors declare no conflict of interest.